Literature DB >> 18725454

High-resolution structure of the stable plasminogen activator inhibitor type-1 variant 14-1B in its proteinase-cleaved form: a new tool for detailed interaction studies and modeling.

Jan K Jensen1, Peter G W Gettins.   

Abstract

Wild-type plasminogen activator inhibitor type-1 (PAI-1) rapidly converts to the inactive latent state under conditions of physiological pH and temperature. For in vivo studies of active PAI-1 in cell culture and in vivo model systems, the 14-1B PAI-1 mutant (N150H-K154T-Q319L-M354I), with its stabilized active conformation, has thus become the PAI-1 of choice. As a consequence of the increased stability, the only two forms likely to be encountered are the active or the cleaved form, the latter either free or complexed with target proteinase. We hereby report the first structure of the stable 14-1B PAI-1 variant in its reactive center cleaved form, to a resolution of 2.0 A. The >99% complete structure represents the highest resolved structure of free cleaved PAI-1. This high-resolution structure should be of great use for drug target development and for modeling protein-protein interactions such as those of PAI-1 with vitronectin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725454      PMCID: PMC2548355          DOI: 10.1110/ps.036707.108

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  29 in total

Review 1.  Serpin structure, mechanism, and function.

Authors:  Peter G W Gettins
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

2.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

3.  Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.

Authors:  H Nar; M Bauer; J M Stassen; D Lang; A Gils; P J Declerck
Journal:  J Mol Biol       Date:  2000-03-31       Impact factor: 5.469

4.  The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.

Authors:  A M Sharp; P E Stein; N S Pannu; R W Carrell; M B Berkenpas; D Ginsburg; D A Lawrence; R J Read
Journal:  Structure       Date:  1999-02-15       Impact factor: 5.006

5.  Structures of active and latent PAI-1: a possible stabilizing role for chloride ions.

Authors:  T J Stout; H Graham; D I Buckley; D J Matthews
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

Review 6.  The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment.

Authors:  Troels Wind; Martin Hansen; Jan K Jensen; Peter A Andreasen
Journal:  Biol Chem       Date:  2002-01       Impact factor: 3.915

7.  Effect of stabilizing versus destabilizing interactions on plasminogen activator inhibitor-1.

Authors:  N Vleugels; J Leys; I Knockaert; P J Declerck
Journal:  Thromb Haemost       Date:  2000-11       Impact factor: 5.249

8.  Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

Authors:  Mesut Eren; Corrie A Painter; James B Atkinson; Paul J Declerck; Douglas E Vaughan
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

9.  The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand.

Authors:  Jan K Jensen; Troels Wind; Peter A Andreasen
Journal:  FEBS Lett       Date:  2002-06-19       Impact factor: 4.124

10.  How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration.

Authors:  Aiwu Zhou; James A Huntington; Navraj S Pannu; Robin W Carrell; Randy J Read
Journal:  Nat Struct Biol       Date:  2003-07
View more
  16 in total

1.  Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies.

Authors:  Kenneth A Botkjaer; Sarah Fogh; Erin C Bekes; Zhuo Chen; Grant E Blouse; Janni M Jensen; Kim K Mortensen; Mingdong Huang; Elena Deryugina; James P Quigley; Paul J Declerck; Peter A Andreasen
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

2.  Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valentina Kon; Agnes B Fogo; Daniel A Lawrence; Ji Ma
Journal:  Lab Invest       Date:  2014-03-31       Impact factor: 5.662

3.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes.

Authors:  Lawrence C Thompson; Sumit Goswami; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

4.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.

Authors:  Lawrence C Thompson; Sumit Goswami; David S Ginsberg; Duane E Day; Ingrid M Verhamme; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

5.  Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1.

Authors:  Jan K Jensen; Klavs Dolmer; Peter G W Gettins
Journal:  J Biol Chem       Date:  2009-05-13       Impact factor: 5.157

6.  Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1.

Authors:  Zhonghui Lin; Longguang Jiang; Cai Yuan; Jan K Jensen; Xu Zhang; Zhipu Luo; Barbara C Furie; Bruce Furie; Peter A Andreasen; Mingdong Huang
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

7.  Crystal structure of plasminogen activator inhibitor-1 in an active conformation with normal thermodynamic stability.

Authors:  Jan K Jensen; Lawrence C Thompson; Joel C Bucci; Poul Nissen; Peter G W Gettins; Cynthia B Peterson; Peter A Andreasen; J Preben Morth
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

8.  1.45 Å resolution structure of SRPN18 from the malaria vector Anopheles gambiae.

Authors:  David A Meekins; Xin Zhang; Kevin P Battaile; Scott Lovell; Kristin Michel
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-11-19       Impact factor: 1.056

9.  The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues.

Authors:  Peter G W Gettins; Klavs Dolmer
Journal:  J Biol Chem       Date:  2015-11-10       Impact factor: 5.157

Review 10.  Serpins in cartilage and osteoarthritis: what do we know?

Authors:  David J Wilkinson
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.